Pertinently, combining venetoclax with the anti-oestrogen tamoxifen markedly improved responses of ER+ breast cancer xenografts that express high BCL-2.101 Of greatest moment would be identifying a therapy that eliminated metastasis, the major killer in cancer. This evidence concerns the gene BCL2 and cancer.